|Description||CysLT1 antagonist Q8 is a cysteinyl leukotreine (CysLT1) receptor antagonist inhibiting angiogenesis in transgenic fluorescent zebrafish, and human microvascular endothelial cell (HMEC-1) proliferation, tubule formation, and migration. CysLT1 antagonist Q8 exhibits antiangiogenic effect in a VEGF-independent in vitro model of angiogenesis and an additive antiangiogenic response with bevacizumab.|
|Brife Description||CysLT1 antagonist|
|Related CAS||1541762-52-0 (free base)|
|Synonyms||Q8 hydrochloride; Q 8 hydrochloride; Q-8 hydrochloride; (E)-2-(2-Quinolin-2-yl-vinyl)-benzene-1,4-diol Hydrochloride|
HLCL65 hydrochloride is a first-in-class inhibitor of PRMT5. HLCL65 selectively inhibits Th1 cell proliferation (IC50 value 1.1 μM). In vivo, HLCL65 suppresses ...
MK785, an imidazol derivative, has been found to inhibit the formation of aortic histamine through influencing the aortic histidine decarboxylase at some extent...
Luciferase is an analytical enzyme used as a component of lysis solution to measure luminescence signals.
Revefenacin, also knownc as TD-4208 and GSK1160724, is potent and selective muscarinic receptor antagonist in development for the treatment of COPD.
Celgosivir hydrochloride is the hydrochloride salt of Celgosivir which is anα-glucosidase inhibitor and inhibits bovine viral diarrhoea virus (BVDV) with an IC5...
Melinamide, also known as AC-223 or Artes, an amide derivative of an unsaturated long-chain fatty acid, is a new hypocholesterolaemic drug, caused a substantial...
Ginsenoside Ro, the predominant ginsenoside in the rhizome, shows no hemolytic nor cytotoxic activities.
AS1949490 has been found to be a selective SHIP2 phosphatase inhibitor and show antidiabetic activities.